AC Immune
ACIU
32 hedge funds and large institutions have $148M invested in AC Immune in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 6 closing their positions.
225% more capital invested
Capital invested by funds: $45.5M → $148M (+$103M)
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
64% more call options, than puts
Call options by funds: $422K | Put options by funds: $258K
14% more funds holding
Funds holding: 28 → 32 (+4)
10.9% more ownership
Funds ownership: 19.11% → 30.01% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$23M |
| 2 |
BlackRock
New York
|
+$7.76M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$6.43M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.82M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$621K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$230K |
| 2 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
-$83.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$60.6K |
| 4 |
LBC
Lawrence B. Cohen
|
-$36.6K |
| 5 |
Renaissance Technologies
New York
|
-$24.4K |
ACIU Hedge Fund Activity: Q4 2023 in Review
32 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2023, worth a combined $148M — up 225% from $45.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ACIU positions and 6 closed out — a net gain of 4 holders — while 9 added to existing stakes and 3 trimmed.
The largest buyer was BVF Inc, adding an estimated $23M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $230K sold.
- 32 institutional investors held AC Immune (ACIU) as of Q4 2023, up from 28 in Q3 2023.
- Funds reported $148M of AC Immune stock for Q4 2023, up 225% quarter-over-quarter.
- 10 funds opened new AC Immune positions in Q4 2023 and 6 closed out, a net change of +4 holders.
- The largest AC Immune buyer in Q4 2023 was BVF Inc, an estimated $23M added.
- The largest AC Immune seller in Q4 2023 was Susquehanna International Group, an estimated $230K sold.
Based on aggregated 13F filings for Q4 2023.